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Abstract 
Reactions of the -diketiminato n-butyl magnesium complex, [HC{(Me)CN(2,6-
i
Pr2C6H3)}2Mg
n
Bu], with a range of substituted pyridines and fused-ring quinolines in 
the presence of PhSiH3 has been found to result in dearomatisation of the N-
heterocyclic compounds. This reaction is proposed to occur through the formation of 
an unobserved N-heterocycle-coordinated magnesium hydride and subsequent 
hydride transfer via the C2-position of the heterocycle prior to hydride transfer to the 
C4-position and formation of thermodynamically-favoured magnesium 1,4-
dihydropyridides. This reaction is kinetically suppressed for 2,6-dimethylpyridine 
while the kinetic product, the 1,2-dihydropyridide derivative, was isolated through 
reaction with 4-methylpyridine (4-methylpyridine) in which case the formation of the 
1,4-dihyropyridide is prevented by the presence of the 4-methyl substituent. X-ray 
structures of the products of these reactions with 4-methylpyridine, 3,5-
dimethylpyridine and iso-quinoline comprise a pseudo-tetrahedral magnesium centre 
while  the regiochemistry of the particular dearomatisation reaction is determined by 
the substitution pattern of the N-heterocycle under observation. The compounds are 
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all air-sensitive and exposure of the magnesium derivatives of dearomatised pyridine 
and 4-dimethylaminopyridine (DMAP) to air resulted in ligand rearomatisation and 
the formation of dimeric μ2-2-2-peroxomagnesium compounds which have also 
been subject to analysis by single crystal X-ray diffraction analysis. An unsuccessful 
extension of this chemistry to N-heterocycle hydrosilylation is suggested to be a 
consequence of the low basicity of the silane reagent in comparison to the pyridine 
substrates which effectively impedes any further interaction with the magnesium 
centres.  
 
Introduction 
While recent interest in the dearomatisation and hydrogenation of aromatic nitrogen 
heterocycles (pyridines, quinolines) has been driven by the prevalence of these 
functions in many natural products and pharmaceuticals,
1
 a number of reductive and 
group 1 and group 13-based dearomatisation strategies have been known for some 
time.
2
 Lansbury’s reagent, [Li{Al(1,4-dihydropyrid-1-yl)4], for example, is generated 
by reaction of LiAlH4 and pyridine and has been known to effect the selective 
reduction of ketones in the presence of carboxylic and ester groups for some fifty 
years.
3
 Applications of these types of reagents in further syntheses where the reduced 
N-heterocyclic core is retained are, however, relatively limited. More attractive, 
therefore, is the development of milder, more conveniently employed and, ideally, 
catalytic reagents suitable for the conversion of a wide range of N-heterocyclic 
substrates to isolable dearomatised derivatives which are then available for use as 
synthons in subsequent multi-step syntheses. Although precedented by several 
heterogeneous processes,
4
 the initial report of homogeneous pyridine hydrosilylation 
was only described in 1998. In this case a [Cp2TiMe2]/PhMeSiH2 system was reported 
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to effect the transformation of a variety of 3- and 4-substituted  and 3,5-disubstituted 
pyridines to the N-silylated 1,2- and 1,4-dihydropyridines or, dependent upon 
substitution patterns, the corresponding tetrahydropyridine products.
5
 This process 
was reasoned to proceed via a Ti-H pyridine coordination/insertion and silane 
metathesis mechanism (Scheme 1) and an inability to dearomatise pyridines with 2- or 
6-substitution patterns was attributed to the substrate steric demands. Although similar 
limitations have been observed in very recent work described by Nikonov and co-
workers, in this case the catalytic ability of the cationic ruthenium complex 
[Cp(
i
Pr3P)Ru(NCCH3)]PF6 to effect hydrosilylation of 3- and 5-substituted pyridines 
to the dihydropyridines was not compromised by the concomitant reduction of these 
products to tetrahydropyridines.
6
  In further related work Crabtree and co-workers 
have developed a reduction of quinolines by silanes in the presence of rhodium or 
iridium catalysts
7
 and a very recent report has described an extension of this chemistry 
to effect a palladium-catalysed silaboration of a variety of pyridines.
8 
 
Scheme 1: Proposed mechanism for the titanocene-catalysed hydrosilylation of 
pyridine.
5
  
 
Our own interest in this area derives from our attempts to develop a catalytic and 
stoichiometric reaction chemistry for the abundant and environmentally benign group 
2 elements heavier than beryllium that takes them beyond their traditional applications 
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as, for example, Grignard reagents or Hauser bases.
9
 Much of this initial work has 
explored the reactivity of the redox-inactive divalent cations of these elements by 
analogy with chemical behaviour previously observed for similarly d
0
 complexes of 
early transition elements or lanthanides in their highest and trivalent oxidation states 
respectively. In this regard, Diaconescu and co-workers have recently shown that both 
N-heterocycle dearomatisation and C-H activation may be combined into an elegant 
group 3-centred scheme which results in C-C coupling reactivity between the two 
relevant heterocycles (Scheme 2).
10
 In earlier work Kiplinger and co-workers had also 
shown that dearomatisation of terpyridines may be readily induced through reaction 
with lanthanide alkyls.
11 
 Although a somewhat ‘lanthanide mimetic’ reactivity has emerged from our 
studies of the group 2-catalysed hydroelementation of C=E multiple bonds (E = CR2, 
NR, O), and examples of N-heterocycle dearomatisation are well precedented in the 
chemistry of groups 1 and 13,
2,3
 examples of well-defined behaviour comparable to 
the second reaction step depicted in Scheme 2 are relatively unexplored for group 2-
based systems. On the basis of a series of detailed NMR spectroscopic investigations, 
van der Kerk and Budzelaar deduced that the outcome of the room temperature 
reaction between MgH2 and pyridine was exclusively the magnesium bis(1,4-
dihydropyridide) isomer, which formed via the intermediacy of short-lived but 
observable 1,2-dihydropyridide species.
12
 In support of these observations we have 
recently reported that reaction of the well-defined β-diketiminato-supported n-
butylmagnesium complex, [HC{(Me)CN(2,6-
i
Pr2C6H3)}2Mg
n
Bu], I, with pyridine in 
the presence of PhSiH3 results in heterocycle dearomatisation by a hydride transfer 
which occurs with the formation of isolable magnesium compounds containing 1,2- 
and 1,4-dihydropyridide anions as the respective kinetic and thermodynamic 
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products.
13
 In this contribution we describe extensions of this behaviour to a range of 
substituted pyridine and quinoline substrates and outline attempts to establish a 
catalytic variant of this reactivity which is reminiscent of the titanocene-based system 
illustrated in Scheme 1. 
 
Scheme 2: Group 3-catalysed pyridine ortho-CH activation and 
dearomatisation/coupling.
10
 
 
Results and Discussion 
We have previously reported that addition of pyridine to a toluene solution of 
compound I results in the rapid and clean formation of the n-butylmagnesium 
pyridine adduct, compound 1 (Scheme 3).
13
 A series of NMR scale reactions 
demonstrated that this process occurs for every monocyclic and fused ring pyridine 
investigated in this study and no evidence for magnesium n-butyl-induced substrate 
dearomatisation was observed even under forcing conditions. This observation 
contrasts markedly with those of Okuda of the reactivity of pyridine with more 
reactive calcium bis-allyl species and our own observations of the reactivity of 
heavier group 2 bis(trimethylsilyl)methanides, [M{CH(SiMe3)2}2(THF)2] (M = Ca, Sr, 
Ba) with bis(imino)pyrines in which case rapid formation of the respective allylated 
and alkylated pyridine was observed upon combination of the reagents.
14.15
 As the 
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reactivity with compound I was assessed to be straightforward and unambiguous, only 
the reaction utilising one equivalent of 2-methylpyridine was repeated on a 
preparative scale resulting in the isolation of pale yellow crystals of compound 2 
which were suitable for an X-ray diffraction analysis. The single crystal X-ray 
structure of the Mg(2)-containing molecule (there are two unique molecules in the 
unit cell) of compound 2 is illustrated in Figure 1 while selected bond length and 
angle data and details of the crystallographic analysis are provided in Tables 1, 2 and 
3 respectively. Like compound 1, compound 2 is a four-coordinate pseudo-tetrahedral 
magnesium complex in which the coordination sphere of the Mg atoms is provided by 
the bidentate -diketiminate ligand and the n-butyl and 2-methylpyridine ligands. The 
bond lengths and angles are perturbed only very slightly from those observed in 
compound 1 and the structure is otherwise unremarkable and will not, therefore, be 
discussed further here.
13 
 
Figure 1: ORTEP representation (25% probability ellipsoids) of the X-ray structure 
of compound 2. Hydrogen atoms and iso-propyl methyl groups are deleted for clarity. 
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 Following the procedure of Jones and Stasch for magnesium hydride 
generation from compound I,
16
 we have previously reported that addition of PhSiH3 to 
a solution of compound 1 or to I in the presence of pyridine results in the formation of 
magnesium compounds containing 1,2- and 1,4-dihydropyridide (identified as 
compound 3 in this submission)  anions as the respective kinetic and thermodynamic 
products. Accordingly a series of preparative scale reactions were undertaken through 
addition of two molar equivalents of the relevant pyridine or quinoline derivative to a 
toluene solution of compound I. For monocyclic pyridine derivatives this gave a 
yellowing of the solution whereas for bicyclic quinoline derivatives a red solution 
formed.  A further molar equivalent of phenylsilane was then added and the reactions 
heated at 60 
o
C for 48 hours. Crystalline samples of compounds 4 – 10 were then 
isolated by slow cooling and crystallisation from the saturated reaction solutions 
(Schemes 3 and 4). 
 
Scheme 3: Dearomatisation of pyridine derivatives by 1 and PhSiH3. 
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The products of 2-methylpyridine (4), 3-methylpyridine (5) and 3,5-lutidine, (7) 
dearomatisation under these conditions were identified as the respective 1,4-
dihydropyridide derivatives by a combination of 
1
H (COSY) and 
13
C NMR 
spectroscopy. In line with the previously reported data of Budzelaar and co-
workers,
12a,b
 in all cases the new sp
3
 CH2 protons were found to resonate between δ 
3.30 and δ 4.00 ppm while the alkenic components of the newly formed 
dihydropyridide substituent were observed as a series of multiplets at chemical shifts 
upfield from the aromatic region; ortho-protons were found within δ 5.4 to δ 6.3 ppm 
and meta-protons shifted to between δ 4.2 to δ 5.0 ppm. In contrast to this behaviour, 
no reaction was observed with 2,6-lutidine, while 4-methylpyridine was converted 
selectively to the 1,2-dihydropyridide derivative, compound 6. Consistent with our 
previous proposal, we interpret these latter observations to indicate that hydride 
transfer generally occurs via an initially formed 1,2-dihydropyridide derivative. In the 
case of 2,6-lutidine this process is completely suppressed by the presence of the two 
methyl groups positioned adjacent to the lutidine nitrogen centre. Similarly, for 
compound 6 the initial 1,2-dihydropyridide is formed but can not then convert to the 
1,4-dihydropyridide observed for compounds  3, 4, 5, 7 or 8. 
 In contrast to the reactivity observed when a methyl group occupies the 4-
position of the pyridine substrate, treatment of 4-dimethylaminopyridine (DMAP) 
under analogous conditions was found to result in the production of a mixture of the 
1,2- and 1,4-hydride transfer products in a 3:1 ratio, which could be converted 
completely to the product of hydride transfer to the 4-position to form compound 8 by 
heating at 60 
o
C in toluene for a further 96 hours. This latter transformation contrasts 
markedly with the previous observation of Jones and Stasch of the similarly four-
coordinate magnesium hydride species, [HC{(
t
Bu)CN(2,6-
i
Pr2C6H3)}2Mg(H)(DMAP)] 
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in which the hydride maintains its integrity as a terminally-bonded ligand.
16
 The 
observation of both potential isomers during the early stages of the reaction implies 
that the ultimate conversion to the symmetrical 1,4-dihydropyridide-containing isomer, 
compound, 8, again occurs under overall thermodynamic control. This observation 
was borne out by calculations performed on model complexes of compound 8, its 1,2-
dihydropyridide isomer and a DMAP-coordinated magnesium hydride species in 
which the complete β-diketiminate ligand was replaced by [HC{(H)CN(Me)}]- in the 
interests of computational expense. Despite this simplification, geometry 
optimisations performed at the B3LYP density functional theory with LAN2DZ 
pseudopotentials (and basis set) implemented in the Gaussian03 suite of programmes 
provided a good approximation of the local bond lengths and angles about each Mg 
atom in comparison to the crystallographically deduced structures (vide infra).
17
 
Consistent with the experimentally observed transformation into compound 8 the 
isomer containing the 1,4-dihydropyridide anion was calculated to be marginally 
lower (1.02 kcal mol
-1
) in total energy than its 1,2-dihydropyridide isomer, while both 
species were more significantly lower (1,2-isomer, 9.01 kcal mol
-1
; 1,4-isomer 10.02 
kcal mol
-1
) than the alternative pyridine-adducted magnesium hydride formulation, 
[HC{(H)CN(Me)}Mg(H)-κ1-NC5H4-4-NMe2]. C5H4N-4-NMe2. These data reflect our 
previous DFT examination of the dearomatisation of pyridine and earlier MNDO 
calculations which assessed the heats of formation, Hf, of the various potential 
isomers of pyridine reduction, albeit with less thermodynamic discrimination between 
the alternative isomeric forms.
13,18
 While the reaction to produce compound 8 is 
effectively identical to that employed by Jones and Stasch to synthesise 
[HC{(
t
Bu)CN(2,6-
i
Pr2C6H3)}2Mg(H)(DMAP)],
16
 the outcome of the two reactions is 
quite different. The dearomatisation-based syntheses reported herein generally 
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required elevated temperatures to occur and, thus, this latter compound may again be 
assigned as a kinetic reaction product, which may display some enhanced kinetic 
stability resulting from the increased steric demands of the tert-butyl-substituted -
diketiminate ligand employed in the earlier study. Analogous calculations performed 
upon model complexes containing dearomatised 4-methylpyridine revealed a similar 
thermodynamic preference of 1.55 kcal mol
-1
 for the formation of the 1,4-
dihydropyridide isomer over the corresponding 1,2-dihydropyridide isomer. We thus 
tentatively ascribe the formation of compound 6 to occur under overall kinetic rather 
than thermodynamic control. 
 The fused ring substrates quinoline and iso-quinoline underwent clean 
dearomatisation to form compounds 9 and 10. In the case of compound 9 complete 
conversion to the 1,4-dihydroquinolide product was observed while for the isomeric 
derivative, compound 10, selective hydride transfer occurred to the 2-carbon centre 
adjacent to the iso-quinoline nitrogen. In this latter case the reaction is necessarily 
unambiguous as the 4-position of the heterocyclic ring is blocked by the fused 
aromatic system (Scheme 4). 
 
Scheme 4: Dearomatisation of quinoline derivatives by 1 and PhSiH3. 
  
 Representative crystal structures of the dearomatised pyridine derivatives were 
acquired after slow crystallisation from toluene at room temperature for the 1,4-
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dihydropyridide derivative of 3,5-lutidine, compound 7, the 1,2-dihydropyridide 
derivative of 4-methylpyridine, compound 6, and the iso-quinoline derivative, 
compound 10. The results of these analyses are presented in Figures 2 – 4, while 
selected bond length and angle data and details of the X-ray experiments are provided 
in Tables 1, 2 and 3 respectively. In a manner similar to the previously described 1,2-
dihydropyridide complex of pyridine itself,
13
 the methylene hydrogen atoms were 
disordered between the 2-carbon and/or 6-carbon centres (C30 and C34) of  the  
reduced methylpyridine moiety of compound 6. These were, thus, omitted from the 
refinement because of the inability to determine precisely which of these best 
represents a CH2 moiety.  
 Each of the three structures feature a pseudo-tetrahedral magnesium atom in 
which the coordination sphere is provided by the bidentate -diketiminate ligand and 
single equivalents of the relevant dearomatised and non-dearomatised pyridine 
derivative. While the magnesium-bound dihydropyridide N(3) centres are not 
significantly pyramidalised [Σbond angles = 6: 359.1
o
; 7: 359.2
o
; 10: 355.3
o
], the pyridine 
and dihydropyridide donors are readily discriminated by the alternation of double and 
single bonds about the deraromatised ligand as well as the non-planarity of the 
heterocycle introduced upon incorporation of the saturated methylene carbon centre. 
The differing bonding modes (covalent/electrostatic versus dative covalent) are also 
reflected in the respective Mg(1)-N(3) [6: 1.993(3); 7: 1.9827(13); 10: 1.9926(16) Å] 
and Mg(1)-N(4) [6: 2.140(3); 7: 2.1282(13); 10: 2.1301(15) Å] distances linking the 
Mg centre to the two heterocycles with the latter distances effectively identical to the 
Mg-NDMAP distance [2.135(3) Å] within the similarly four-coordinate magnesium 
hydride species, [HC{(
t
Bu)CN(2,6-
i
Pr2C6H3)}2Mg(H)(DMAP)], in which the hydride 
maintains its integrity as a terminally-bonded ligand.
16 
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Figure 2: ORTEP representation (25% probability ellipsoids) of the X-ray structure 
of compound 7. Hydrogen atoms except those attached to C(32) and iso-propyl 
methyl groups are deleted for clarity. 
 
 
Figure 3: ORTEP representation (25% probability ellipsoids) of the X-ray structure 
of compound 6. Hydrogen atoms and iso-propyl methyl groups are deleted for clarity. 
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Figure 4: ORTEP representation (25% probability ellipsoids) of the X-ray structure 
of compound 10. Hydrogen atoms except those attached to C(30) and iso-propyl 
methyl groups are deleted for clarity. 
  
 The aluminate derivative, Lansbury’s reagent,3 and previously reported 
dihydropyridide derivatives of magnesium and zinc have been reported as air-
sensitive and to behave as selective reducing agents for a variety of organic 
substrates.
12,19
 Although none of this latter reactivity will be reported in this 
submission, all of the compounds 3 – 10, were found to display a marked sensitivity 
toward molecular and/or atmospheric oxygen. Exposure of reaction solutions or 
solutions of the isolated compounds to the open atmosphere was observed to result in 
rapid decolourisation of the distinctive (red or orange) colours attributed to the 
formation of the dearomatised pyridine species. In two cases, the previously reported 
1,4-dihydropyridide derivative, 3, and the product of DMAP dearomatisation, 
compound 8, serendipitous reactions with atmospheric O2 were found to result in the 
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formation of isolable quantities of the well-defined dimeric magnesium peroxide 
species, compounds 11 and 12. The compounds were characterised by 
1
H and 
13
C 
NMR spectroscopy and, in the case of 11, by CHN microanalysis. X-ray diffraction 
analyses were performed on both compounds after crystallisation from saturated 
solutions in toluene at room temperature. The molecular structures of compounds 11 
and 12 are shown in Figures 5 and 6, while selected bond length and angle data and 
details of the X-ray analyses are provided in Tables 1, 2 and 3 respectively. The 
structures of both compounds were found to be centrosymmetric and to contain five-
coordinate Mg centres in which the coordination sphere of each group 2 atom is 
provided by a single bidentate -diketiminate ligand, a molecule of the relevant 
pyridine donor (11, pyridine; 12, DMAP) and a side-on -2-2-O2 peroxide dianion 
which bridges symmetrically between the two magnesium atoms. Although two 
peroxo-centred mixed metal magnesium/alkali metal ‘inverse crown’ structures, 
[{[(Me3Si)2N]4M2Mg2(O2)}∞] (M = K or Li) have been reported previously,
20
 
compounds 11 and 12 appear to be the first examples of monometallic magnesium 
peroxo species. The Mg-O bond lengths within the structures of compounds 11 
(1.9583(12), 1.9716 Å) and 12 (1.969(3), 1.972(3) Å ) are shorter than those observed 
in the potassium ‘inverse crown’ species (2.010(2), 2.015(1) Å),20b while the O-O 
separation of the peroxide units of the pyridine coordinated compounds (11, 1.625(5); 
12, 1.638(5) Å)  is somewhat longer than in both of the previously reported 
[{[(Me3Si)2N]4M2Mg2(O2)}∞] systems (M = K, 1.583; M = Li, 1.551 Å). While these 
latter measurements for compounds 11 and 12 are undoubtedly long, they are not 
unprecedented and similar distances have been observed in several high oxidation 
state early metal derivatives such as tetrafluoro(2-methylpyridine-N-
oxide)peroxotantalate(V) (1.67(5) Å)
21
 and in a dimeric tetraaryl porphyrin 
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hafnium(IV) complex (1.618 Å).
22
 We are satisfied to discount the possibility that 
compounds 11 and 12 are μ-hydroxo species through comparison with the previously 
reported THF-solvated complex [HC{(Me)CN(2,6-
i
Pr2C6H3)}2Mg(OH)(THF)]2, 
which bears the same -diketiminate ligand.23 In this case the O-O separation is 
elongated to more than 2.46 Å and the relevant O-Mg-O′ bond angles are 
consequently considerably more obtuse (76.78
o
 versus 48.8
o
 for 11 and 49.14(13)
o
 for 
12). 
 
Figure 5: ORTEP representation (25% probability ellipsoids) of the X-ray structure of 
compound 11. Hydrogen atoms and iso-propyl methyl groups are deleted for clarity. 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y,-z+2. 
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Figure 6: ORTEP representation (25% probability ellipsoids) of the X-ray structure of 
compound 12. Hydrogen atoms and iso-propyl methyl groups are deleted for clarity. 
Symmetry transformations used to generate equivalent atoms: #1 -x+2,-y,-z. 
  
 The possibility of a magnesium-catalysed hydrosilylation/dearomatisation 
procedure reminiscent of the titanium-catalysed process illustrated in Scheme 1 is 
dependent upon consecutive magnesium hydride-induced dearomatisation and 
subsequent Si-H/Mg-N metathesis steps (Scheme 5). The viability of the first of these 
processes for a variety of pyridine derivatives is clearly demonstrated by the isolation 
of compounds 3 – 10, while we have previously employed the latter metathesis 
reactivity between [Mg{N(SiMe3)2}2] and PhSiH3 to synthesise a high nuclearity 
magnesium hydride species.
24
 Reactions between the pyridine derivative, 3, and the 
quinoline and iso-quinoline complexes, compounds 9 and 10, with an excess of 
PhSiH3 were, thus, studied on an NMR scale. Monitoring of reactions in d8-toluene 
performed at 60 
o
C for a period of one week evidenced no conversion of the pyridine 
starting materials, while heating to 90 
o
C caused the -diketiminato magnesium 
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complexes to begin to decompose with the liberation of the free di-imine ligand. 
Similarly, attempted catalytic reactions of 10 mol% of the magnesium n-butyl 
complex, I, with pyridine and PhSiH3 at 60 
o
C provided ca. 10 % consumption of the 
pyridine and silane reagents and stoichiometric formation of compound 3 based upon 
the starting quantity of compound I employed. It appears, therefore, that the silane 
reagent employed as a potential source of hydride is insufficiently reactive to engage 
in any further metathesis reactivity with the magnesium dihydropyridide species. We 
believe that this lack of reactivity is due to the low Lewis basicity of the silane in 
comparison to the pyridine substrates and a consequent inability to engage the Mg-N 
bond in an appropriate metathesis transition state (inset, Scheme 5). 
 
Scheme 5: Proposed mechanism for the magnesium-catalysed hydrosilylation of 
pyridine derivatives. 
  
 In summary, we have observed that reactions of in situ generated magnesium 
hydrides and aromatic pyridine derivatives result in N-heterocycle dearomatistion 
which generally results in the formation of well-defined 1,4-dihydropyridide 
derivatives as the thermodynamic reaction products. We are continuing to study the 
reductive reactivity of these well defined species and to elaborate their reactions with 
more potent hydride sources in attempts to achieve some level of catalytic pyridine 
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heterofunctionalisation with this abundant and benign element and its heavier group 2 
congeners. This work will be reported in subsequent publications. 
 
Experimental Section 
All manipulations were carried out using standard Schlenk line and glovebox 
techniques under an inert atmosphere of either nitrogen or argon. NMR experiments 
were conducted in Youngs tap NMR tubes made up and sealed in a Glovebox. NMR 
data were collected on a Bruker AV300 spectrometer operating at 75.5 MHz (
13
C). 
Solvents (Toluene, THF, hexane) were dried by passage through a commercially 
available (Innovative Technologies) solvent purification system, under nitrogen and 
stored in ampoules over molecular sieves. C6D6 and d8-toluene were purchased from 
Goss Scientific Instruments Ltd. and dried over molten potassium before distilling 
under nitrogen and storing over molecular sieves. Compounds I and 3 were 
synthesised by literature procedures and all silanes and pyridine substrates were 
purchased from Sigma-Aldrich.
25
 CHN microanalysis was performed by Mr Stephen 
Boyer of London Metropolitan University. In NMR assignments Dipp = 2,6-di-iso-
propylphenyl. 
 
Synthesis of Compound 2 
Compound I (0.75 g, 1.51 mmol) was dissolved in toulene (10 mL) and a solution of 
2-methylpyridine (0.14g, 1.72 mmol) in toluene (2 mL) was added at room 
temperature. The resulting pale yellow solution was stirred for one hour. The solution 
was concentrated and 2 was isolated as pale crystals after storage at –30 oC. (0.67 g, 
75%). 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm):  1.40 (24H, d, JHH = 6.9 Hz, 
CH(CH3)2), 1.95 (6H, s, NC(CH3), 3.45 (2H, m, CH(CH3)2), 5.21 (1H, s, 
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NC(CH3)CH), 6.68 (2H, s, NCHCH), 6.70 (2H, s, NC(CH3)CH), 7.07 (2H, t, JHH = 
7.8 Hz, NCHCHCH), 7.35 (6H, s, Ar-H), 9.02 (2H, s, NCH). 
13
C NMR (75.5 MHz, 
C6D6, 300 K) δc (ppm):  168.44 (s, NCH), 159.71 (s, NC(CH3)), 150.71 (s, NC (Ar)), 
146.64 (s, NCHCHCH), 142.92 (s, p-C6H3), 138.27 (s, NC(CH3)), 125.51 (s, 
NC(CH3)CH), 124.15 (s, m-C6H3), 121.59 (s, NCHCH), 95.20 (s, NC(CH3)CH), 
32.75 (s, CH(CH3)2), 32.31 (s, CH(CH3)2), 28.74 (s, NC(CH3)), 24.82 (s, NC(CH3)), 
24.63 (s, CH(CH3)2), 24.45 (s, CH(CH3)2). Elemental analysis (%) for C39H57MgN3 
(found); C 79.09 (78.91); H 9.72 (9.60); N 7.10 (7.00). 
 
General procedure for dearomatisation reactions 
Compound I (1 mmol, 500 mg) was dissolved in toluene (ca. 5 mL) followed by the 
addition of 1 equivalent of the relevant pyridine or quinoline derivative. The reactions 
were then stirred at room temperature overnight before further equivalents of the N-
heterocycle and phenyl silane were added. The reactions were then heated to 60 
o
C for 
48 hrs, before cooling and concentration of the solution provided crystalline products 
suitable for isolation by filtration in ca. 50 – 60% yield. 
 
Compound 4 (dearomatisation of 2-methylpyridine) 
1
H NMR (300MHz, C6D6, 300K) δH (ppm): 0.72 (6H, d, JHH = 9 Hz, CH(CH3)2), 0.87 
(6H, d, JHH = 6 Hz, CH(CH3)2), 1.50 (6H, d, JHH = 6 Hz, CH(CH3)2), 1.76 (6H, d, JHH 
= 6 Hz, CH(CH3)2), 2.10 (3H, s, NC(CH3)CHCH2), 2.13 (9H, br.s, NC(CH3)), 2.98 
(2H, m, CH(CH3)2), 3.29 (2H, m, CH(CH3)2), 4.05 (2H, s, NCHCHCH2), 4.59 (1H, m, 
NC(CH3)CHCH2), 4.74 (1H, m, NCHCHCH2), 5.44 (1H, s, (NC(CH3))2CH), 5.82 (1H, 
d, JHH = 6 Hz, NCHCHCH2), 6.79 (2H, m, m-Pyr), 7.16 (1H, m, p-Pyr), 7.45 – 7.66 
(6H, m, Ar), 9.37 (1H, m, o-Pyr). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 
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169.59 (o-Pyr), 139.39 (m-Pyr), 139.08 (m-Pyr), 126.11, 125.20, 123.99, 95.76 
((NC(CH3))2CH), 93.33 (NC(CH3)CHCH2), 92.49 (NCHCHCH2), 29.33 
(NCHCHCH2), 28.30 (CH(CH3)2), 25.26 (NC(CH3)-Pyr), 25.15  (NC(CH3)CHCH2), 
25.02 (CH(CH3)2), 24.72 (CH(CH3)2). Elemental analysis (%) for C41H56MgN4 
(found); C 78.31 (78.09); H 8.95 (8.84); N 8.67 (8.80). 
 
Compound 5 (dearomatisation of 3-methylpyridine) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.35 (6H, d, JHH = 6Hz, (CH3)2CH), 
1.08 (6H, d, JHH = 6Hz, (CH3)2CH), 1.30 (6H, d, JHH = 6Hz, (CH3)2CH), 1.51 (3H, s, 
NCHC(CH3)CH2, 1.54 (3H, s, NCHC(CH3)(CH)3), 1.68 (6H, d, JHH = 9Hz, 
(CH3)2CH), 1.75 (6H, s, NC(CH3)CH), 2.82 (2H, m, (CH3)2CH), 3.53 (2H, m, 
NCHC(CH3)CH2(CH)2), 3.64 (2H, m, (CH3)2CH), 4.30 (1H, m, NCHCHCH2), 4.92 
(1H, s, NC(CH3)CH), 5.29 (1H, s, NCHC(CH3)), 5.65 (1H, d, JHH = 6Hz, 
NCHCHCH2), 6.36 (1H, m, m-Pyr), 6.67 (1H, d, JHH = 6Hz, p-Pyr), 7.03 (2H, m, m-
Ar(Diip)), 7.17 (2H, m, p-Ar(Dipp)), 7.28 (2H, m, m-Ar(Dipp)), 8.25 (2H, m, o-Pyr). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 169.48 (o-Pyr), 145.42, 143.76, 142.23, 
138.16 (NCHCH2), 133.54 (NCHC(CH3)), 125.88, 124.87, 123.90, 100.41 
(NC(CH3)CH), 94.40 (NCHC(CH3)), 92.51 (NCHCH), 31.80 (NCHCHCH2), 29.52 
(CH(CH3)2), 28.43 (CH(CH3)2), 25.35 (CH(CH3)2), 24.77(CH(CH3)2), 24.56 
(CH(CH3)2), 24.47 (CH(CH3)2), 24.35 (NC(CH3)2), 22.96 (CH3- 3Pic), 18.00 
(NCHC(CH3)CH2). Elemental analysis (%) for C41H56MgN4 (found); C 78.26 (78.09); 
H 8.97 (8.84); N 8.90 (8.80). 
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Compound 6 (dearomatisation of 4-methylpyridine) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.38 (6H, d, JHH = 6Hz, (CH3)2CH), 
1.10 (6H, d, JHH = 6Hz, (CH3)2CH), 1.29 (6H, d, JHH = 6Hz, (CH3)2CH), 1.55 (3H, s, 
Pyr-CH3), 1.57 (6H, d, JHH = 6Hz, (CH3)2CH), 1.76 (6H, s, NC(CH3)CH), 1.95 (3H, s, 
NCH2CHC(CH3)), 2.82 (2H, m, (CH3)2CH), 3.58 (2H, d, JHH = 3Hz, NCH2), 3.64 (2H, 
m, (CH3)2CH), 4.32 (1H, m, NCH2CH), 4.94 (1H, s, NC(CH3)CH), 4.99 (1H, m, 
NCHCH), 6.17 (1H, d, JHH = 6Hz, NCH), 6.32 (2H, d, JHH = 6Hz, m-Pyr), 7.04 (2H, 
m, m-Ar(Dipp)), 7.16 (2H, m, p-Ar(Dipp)), 7.25 (2H, m, m-Ar(Diip)), 8.42 (2H, d, 
JHH = 6Hz, o-Pyr). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 169.59 (o-Pyr), 
148.77, 145.37, 143.49, 142.28, 135.81 (NCH), 126.02, 124.82, 124.00, 98.03 
(NC(CH3)CH), 94.48 (NCHCH2), 94.42 (NCH2CH), 48.71 (NCH2), 29.49 
(CH(CH3)2), 28.43 (CH(CH3)2), 25.22 (CH(CH3)2), 24.82 (CH(CH3)2), 24.37 
(NC(CH3)2), 24.33 (CH(CH3)2), 21.59 (CH3- 4-Pic), 20.96 (NCH2CHC(CH3)). No 
meaningful microanalytical data could be obtained for this compound. 
 
Compound 7 (dearomatisation of 3,5-lutidine) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.41 (6H, d, JHH = 6Hz, (CH3)2CH), 
1.09 (6H, d, JHH = 6Hz, (CH3)2CH), 1.29 (6H, d, JHH = 6Hz, (CH3)2CH), 1.58 (6H, d, 
JHH = 6Hz, (CH3)2CH), 1.61 (6H, s, N(CHC(CH3))2CH2), 1.62 (6H, s, 
N(CHC(CH3)2CH), 1.77 (6H, s, NC(CH3)), 2.87 (2H, m, (CH3)2CH), 3.33 (2H, s, 
N(CHC(CH3)2CH2), 3.64 (2H, m, (CH3)2CH), 4.93 (1H, s, NC(CH3)CH), 5.42 (2H, s, 
NCH), 6.56 (1H, s, p-Pyr), 7.04 (2H, m, m-Ar(Dipp)), 7.19 (2H, p-Ar(Dipp)), 7.28 
(2H, m, m-Ar(Dipp)), 8.03 (2H, s, o-Pyr). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc 
(ppm): 169.41 (o-Pyr), 147.17, 145.69, 143.98, 142.28, 140.95, 135.08, 133.17 
(NCHC(CH3)CH2), 125.78, 124.91, 123.82, 98.88 (NC(CH3)CH), 94.33 
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(NCHC(CH3)CH2), 37.79 (NCHC(CH3)CH2), 29.46 (CH(CH3)2), 28.49 (CH(CH3)2), 
25.36 (CH(CH3)2), 24.62 (CH(CH3)2), 24.52 (CH(CH3)2), 24.38 (NC(CH3)), 22.72 
(CH3- 3,5Lut), 17.93 (NCHC(CH3)CH2). Elemental analysis (%) for C43H60MgN4 
(found); C 78.58 (78.10); H 9.20 (8.77); N 8.52 (8.14). 
 
Compound 8 (dearomatisation of 4-dimethylaminopyridine) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.80 (6H, d, JHH = 9 Hz, CH(CH3)), 1.33 
(6H, d, JHH = 6 Hz, CH(CH3)), 1.49 (6H, d, JHH = 6 Hz, CH(CH3)), 1.77 (6H, d, JHH = 
9 Hz, CH(CH3)), 1.97 (NC(CH3)), 2.16 (6H, s, HN(CH3)2), 2.80 (6H, s, N(CH3)2), 
3.20 (2H, m, CH(CH3)), 3.77 (1H, m, CH(CH3)), 3.88 (2H, m, CH(CH3)), 3.91 (2H, 
m, NCHCHCH(N(CH3)2)), 5.15 (1H, s, NC(CH3)CH), 5.86 (NCH), 6.43 (1H, t, JHH = 
6 Hz, NCHCHCH(N(CH3)2), 7.23 – 7.49 (8H, m, Ar), 8.32 (2H, m, o-Pyr). 
13
C NMR 
(75.5 MHz, C6D6, 300 K) δc (ppm): 169.87 (o-Pyr), 146.63, 143.62, 142.19, 138.57, 
135.89, 130.21, 126.43, 126.12, 125.16, 124.01 (NCHCHC(H)(NMe2)), 122.13, 
118.71, 117.67, 94.95 ((NC(CH3))2CH), 92.37 (NCHCHCH(NMe2)), 29.38 
(NCHCHC(N(CH3)2), 27.87 (NCHCHCH(N(CH3)2), 25.21 (CH(CH3)2), 25.12 
(CH(CH3)2) 24.35 (CH(CH3)2), 23.55 (CH(CH3)2). Elemental analysis (%) for 
C43H32MgN4 (found): C 75.14 (75.26); H 9.09 (8.97); N 12.23 (12.18). 
 
Compound 9  (dearomatisation of quinoline) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): -0.06 (6H, d, JHH = 6Hz, (CH3)2CH), 
0.79 (6H, d, JHH = 6Hz, (CH3)2CH), 1.25 (6H, d, JHH = 6Hz, (CH3)2CH), 1.34 (6H, d, 
JHH = 6Hz, (CH3)2CH), 1.77 (6H, s, NC(CH3), 2.73 (2H, m, (CH3)2CH), 3.61 (2H, m, 
(CH3)2CH), 3.94 (2H, m, NCHCHCH2), 4.24 (1H, m, NCHCH), 5.26 (1H, 
NC(CH3)CH), 5.41 (1H, m, NCH), 5.44 (1H, m, NCCH), 6.20 (1H, m, 3-H-Quin), 
 - 23 - 
6.34 (1H, m, NC(CH)2CH), 6.60 (1H, m, NCCHCH), 6.89 (1H, m, N(CH)2CH2CCH), 
6.91 – 7.28 (9H, m, Ar), 7.57 (1H, m, 7-H-Quin), 8.67 (1H, d, JHH = 6Hz, 8-H-Quin), 
9.08 (1H, s, 2-H-Quin). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 169.87 (NC), 
169.71 (NCH), 155.60, 150.70, 146.67, 146.38, 143.74, 143.62, 142.19, 138.57, 
135.89, 130.21, 126.43, 125.14, 124.01 (NCHCHCH2), 122.13, 118.71, 117.67, 94.95 
(NC(CH3)CH), 92.37 (NCHCHCH2), 29.58 (CH(CH3)2), 29.38 (NCHCHCH2), 27.87 
(CH(CH3)2), 25.21(CH(CH3)2), 25.12 (CH(CH3)2), 25.00 (CH(CH3)2), 24.75 
(CH(CH3)2), 24.35 (NC(CH3), 23.55 (CH(CH3)2). Elemental analysis (%) for 
C47H56MgN4 (found); C 80.50 (80.38), H 8.05 (8.08); N 7.99 (7.92). 
 
Compound 10 (dearomatisation of iso-quinoline) 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.08 (6H, d, JHH = 9Hz, (CH3)2CH), 0.98 
(6H, d, JHH = 6Hz, (CH3)2CH), 1.27 (6H, d, JHH = 6Hz, (CH3)2CH), 1.48 (6H, d, JHH = 
9Hz, (CH3)2CH), 1.78 (6H, s, NC(CH3), 2.82 (2H, m, (CH3)2CH), 3.63 (2H, m, 
(CH3)2CH), 3.94 (2H, s, NCH2), 5.00 (1H, s, NC(CH3)CH), 5.54 (1H, d, JHH = 6Hz, 
NCHCH), 6.31 (1H, d, JHH = 6Hz, NCH), 6.64 (1H, d, JHH = 6Hz, NCH2CCH), 6.92 – 
7.25 (14H, m, Ar-H), 8.33 (1H, s, 2-H-iQuin), 8.69 (1H, s, 8-H-iQuin). 
13
C NMR 
(75.5 MHz, C6D6, 300 K) δc (ppm): 169.79 (NCH), 145.20, 142.49, 136.80, 133.26, 
129.67, 128.80, 126.08, 124.86, 124.17, 121.72, 119.64 (NCHCH), 94.55 
(NC(CH3)CH), 52.82 (NCH2), 29.47 (CH(CH3)2), 28.32 (CH(CH3)2), 25.25 
(CH(CH3)2), 24.87 (CH(CH3)2), 24.50 (CH(CH3)2), 24.38 (NC(CH3). Elemental 
analysis (%) for C47H56MgN4 (found); C 80.50 (80.38); H 8.05 (7.91); N 7.99 (7.83). 
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Compound 11  
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm): 0.65 (12H, d, JHH = 6 Hz, CH(CH3)2), 
1.15 (12H, d, JHH = 9 Hz, CH(CH3)2), 1.66 (12H, s, NC(CH3), 3.05 (8H, m, 
CH(CH3)2), 4.97 (2H, s, NC(CH3)CH), 6.79 (4H, m, NCH2CH2), 6.99-7.15 (14H, m, 
Ar), 8.61 (4H, s, NCH2). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 168.59 (s, 
NCH2), 148.68 (s, N(CH2)2CH), 142.65 (s, NCH2CH2), 129.66 (s, CCH2), 126.03, 
124.65, 123.96, 64.64 (s, NC(CH3)CH), 28.61, 25.88, 25.31, 24.59, 21.76. Elemental 
analysis (%) for C68H92N6Mg2O2 (found): C 76.04 (75.93); H 8.63 (8.52); N 7.82 
(7.84). 
 
Compound 12 
1
H NMR (300 MHz, C6D6, 300 K) δH (ppm):  0.80 (12H, d, JHH = 9 Hz, CH(CH3)), 
1.33 (12H, d, JHH = 6 Hz, CH(CH3)), 1.97 (12H, s, NC(CH3)), 2.80 (6H, s, N(CH3)2), 
3.20 (4H, m, CH(CH3)), 5.15 (2H, s, NC(CH3)CH), 7.23 – 7.49 (16H, m, Ar), 8.32 
(4H, m, o-Pyr). 
13
C NMR (75.5 MHz, C6D6, 300 K) δc (ppm): 169.87 (o-Pyr), 146.63, 
143.62, 142.19, 138.57, 135.89, 130.21, 126.43, 126.12, 125.16, 122.13, 118.71, 
117.67, 94.95 ((NC(CH3))2CH), 29.38 (NCHCHC(N(CH3)2), 27.87 
(NCHCHCH(N(CH3)2), 25.21 (CH(CH3)2), 25.12 (CH(CH3)2) 24.35 (CH(CH3)2), 
23.55 (CH(CH3)2). No meaningful microanalytical data could be obtained for this 
compound. 
 
X-ray Crystallography 
Data for 2, 6, 7, 10, 11 and 12 were collected at 150 K on a Nonius Kappa CCD 
diffractometer equipped with an Oxford Cryosystem low temperature device, using 
graphite monochromated MoKα radiation (λ= 0.71073 Å). Data were processed using 
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the Nonius Software.
26
 Structure solution, followed by full-matrix least squares 
refinement was performed using the programme suite X-SEED for compounds for 2, 
6, 7, 10 and 11 while WINGX-1.70
27,28
 was used for compound 12.  Noteworthy 
points related to the structure determinations follow. 
 The asymmetric unit of 2 consisted of 2 molecules. Disorder was modeled as 
follows: the ligand based on N(3) was modeled over 2 positions in a 50:50 ratio,  
while that based on N(6) in addition to the butyl group based on C(30) were modeled 
over 2 sites in a 70:30 split. Disordered aromatic groups were treated as rigid 
hexagons in the refinement and only partial atoms with 50% occupancy or above were 
refined anisotropically. For 6 data were truncated to a Bragg angle of 25
o
 due to a 
decline of diffraction intensity beyond this point. This is most likely to be related to 
the small crystal dimension. The electron density in the reduced methylpyridine 
moiety based on N(3) was quite smeared, and suggested that this functionality may be 
disordered. However, ardent efforts to model the same over two sites did not improve 
convergence. The hydrogens attached to C(30) and C(34) have been omitted from the 
refinement because of an inability to determine precisely which of these best 
represents a CH2 moiety. For 10 the asymmetric unit comprised half of a dimer 
molecule plus a small region of disordered solvent. Both fragments straddled 
inversion centres. The solvent bore a resemblance to toluene, but because of the 
symmetry imposed disorder and its diffuse nature, it could not be modeled in any 
logical way. Hence PLATON SQUEEZE was employed, and allowance has been 
made herein for the presence of one molecule of toluene per unit cell based on the 
results from using this algorithm.
29
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Electronic Supplementary Information (ESI) available: CCDC 831736 – 831741 
contain the supplementary crystallographic data for this paper. 
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Table 1. Selected bond lengths (Å) for compounds 2, 6, 7, 10, 11 and 12 
 
 2
 
6
 
7
 
10
 
11
 
12
 
Mg(1)-N(1)                        2.074(2)
a 
2.04793) 2.0521(12) 2.0289(15) 2.1090(17) 2.141(3) 
Mg(1)-N(2)                       2.075(2)
b 
2.044(2) 2.0555(12) 2.0347(15) 2.1073(18) 2.112(3) 
Mg(1)-N(3) 2.216(4)
c 
1.993(3) 1.9827(13) 1.9926(16) 2.1966(19) 2.160(3) 
Mg(1)-N(4)                        2.144(5)
d,e 
2.044(2) 2.1282(13) 2.1301(15) 1.9716
f
 1.969(3)
f
 
N(3)-C(30) 
N(3)-C(34) 
C(30)-C(31) 
C(31)-C(32) 
C(32)-C(33) 
C(33)-C(34)                        
- 
- 
- 
- 
- 
-
1.418(5) 
1.401(4) 
1.341(5) 
1.439(6) 
1.426(6) 
1.308(5) 
1.394(2) 
1.386(2) 
1.334(2) 
1.503(2) 
1.504(2) 
1.340(2) 
1.468(3) 
1.356(3) 
1.502(3) 
1.422(4) 
1.431(4) 
1.366(3) 
1.9583(12)
g 
- 
- 
- 
- 
- 
1.972(3)
g 
- 
- 
- 
- 
- 
 
 
a
 Mg(2)-N(4) 2.073(2); 
b
 Mg(2)-N(5) 2.081(2); 
c
 Mg(2)-N(6) 2.2058; 
d
 Mg(1)-C(30); 
e
 
Mg(2)-C(69) 2.118(3); 
f
 Mg(1)-O(1); 
g
 Mg(1)-O(1)′. 
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Table 3: Selected bond angles (
o
) for compounds 2, 6, 7, 10, 11 and 12 
 
 2
 
6
 
7
 
10
 
11
 
12
 
N(1)-Mg(2)-N(2)                91.32(9) 92.36(10) 93.55(5) 95.89(6) 89.00(7) 88.70(11) 
N(1)-Mg(1)-N(3) 109.94(17) 125.65(11) 122.64(5) 124.10(7) 100.40(7) 97.94(12) 
N(1)-Mg(1)-N(4) 114.40(17)a 107.60(10) 107.33(5) 103.52(6) 107.21(5)
c
 107.00(11)
c 
N(2)-Mg(1)-N(3) 107.35(17) 118.74(12) 124.93(6) 120.59(7) 148.55(5)
d
 149.27(13)
d
 
N(2)-Mg(1)-N(4) 128.91(19)b 106.94(10) 101.06(5) 106.00(6) 151.54(7)
e
 149.44(13)
e
 
N(3)- Mg(1)-N(4) - 103.30(12) 104.75(6) 104.6896) 106.19(6)
f
 105.44(11)
f 
Mg(1)-N(3)-C(30) - 122.6(2) 126.46(10) 121.98(13) 48.8
g
 49.14(13)
g
 
Mg(1)-N(3)-C(34) - 126.9(2) 119.85(10) 121.19(13) -  
C(30)-N(3)-C(34) - 109.6(3) 112.89(12) 112.17(17) -  
 
a
 N(1)-Mg(1)-C(30); 
b
 N(2)-Mg(1)-C(30); 
c
 N(1)-Mg(1)-O(1); 
d
 N(2)-Mg(1)-O(1); 
e
 N(1)-Mg(1)-O(1)′; N(2)-Mg(1)-O(1)′; O(1)-Mg(1)-O(1)′.
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Table 1. Crystallographic data for compounds 2, 6, 7, 10, 11 and 12 
 2 6 7 10 11 12 
Molecular formula C39H57LiMgN3 C41H56MgN4 C43H60MgN4 C47H56MgN4 C71.5H96Mg2N6O2 C72H102Mg2N8O2 
Formula weight (g mol
-1
) 592.19 629.21 657.26 701.27 1120.16 1160.24 
Crystal system monoclinic monoclinic orthorhombic monoclinic monoclinic monoclinic 
Space group P21/c C2/c P212121 P2/a P21/n P21/n 
a (Å) 15.8710(2) 35.9897(12) 10.5988(1) 18.3245(2) 13.0076(2) 14.1320(7) 
b (Å) 24.1760(4) 15.3126(3) 18.1105(2) 10.8579(1) 14.3714(2) 13.7311(5) 
c (Å) 19.3490(3) 14.6944(5) 21.0057(2) 22.0748(3) 18.6803(3) 17.9409(11) 
 (deg) 90 90 90 90 90 90 
 (deg) 98.312(1) 105.416(1) 90 108.966(1) 94.299(1) 95.414(3) 
 (deg) 90 90 90 90 90 90 
V (Å
3
) 7346.17(19) 7806.7(4) 4032.04(7) 4153.68(8) 3482.22(9) 3465.9(3) 
Z 8 8 4 4 2 2 
μ (mm-1) 0.077 0.077 0.077 0.079 0.080 0.083 
 (g cm-3) 1.071 1.071 1.083 1.121 1.068 1.112 
θ range (o) 4.27 to 27.48 4.04 to 25.02 3.54 to 27.52 3.98 to 27.48 3.53 to 27.48 4.68 to 25.15 
R1, wR2 [I > 2σ(I)] 0.0663, 0.1442 0.0663, 0.1561 0.0384, 0.0980 0.0523, 0.1217 0.0723, 0.2008 0.0845, 0.2027 
R1, wR2 (all data) 0.1506, 0.1919 0.1199, 0.1913 0.0426, 0.1014 0.0812, 0.1403 0.0909, 0.2128 0.1291, 0.2394 
Measured/independent 
reflections/ Rint 
133599 / 16753 / 
0.1155 
55881 / 6839 /  
0.0882 
55112 / 9226 /  
0.0481 
61721 / 9439 /  
0.0599 
55826 / 7938 /  
0.0477 
24351 / 6008 / 
 0.1851 
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Reaction of N-heterocycles with magnesium hydride species generated by reaction of a 
magnesium n-butyl precursor with phenyl silane results in heterocycle dearomatisation by a 
hydride transfer which occurs with the formation of magnesium compounds containing 
dearomatised dihydropyridide anions.  
 
 
 
 
